MRSA eradication in dermatologic outpatients - Theory and practice;Ambulante MRSA-Sanierung in der Dermatologie - Behandlungsbedarf und Versorgungsrealität

JDDG - Journal of the German Society of Dermatology

Volumn 10, Issue 3, 2012, Pages 186-196

  Meyer, Volker ^a   Kerk, Nina ^a   Mellmann, Alexander ^a   Friedrich, Alexander ^a,b   Luger, Thomas A ^a   Goerge, Tobias ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

MRSA; outpatients; spa types; therapy

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; DOXYCYCLINE; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; DRUG COST; ERADICATION THERAPY; HOSPITAL INFECTION; HUMAN; INFECTION RISK; LIVESTOCK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONITORING; NONHUMAN; OUTPATIENT; RISK ASSESSMENT; SYSTEMIC THERAPY; TREATMENT OUTCOME; WOUND INFECTION;

EID: 84858332195     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2011.07861.x     Document Type: Article

References (22)

1. Kock R, Brakensiek L, Mellmann A, Kipp F, Henderikx M, Harmsen D, Daniels-Haardt I, von Eiff C, Becker K, Hendrix MG, Friedrich AW,. Cross-border comparison of the admission prevalence and clonal structure of meti-cillin-resistant Staphylococcus aureus. J Hosp Infect 2009; 71: 320-6.
2. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR,. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39: 776-82. (Pubitemid 39244289)
3. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y,. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-9. (Pubitemid 36099097)
4. Kock R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torne A, Witte W, Friedrich AW,. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Sur-veill 2010; 15: 19688.
5. Diller R, Sonntag AK, Mellmann A, Grevener K, Senninger N, Kipp F, Friedrich AW,. Evidence for cost reduction based on pre-admission MRSA screening in general surgery. Int J Hyg Environ Health 2008; 211: 205-12. (Pubitemid 351249218)
6. Jappe U, Heuck D, Strommenger B, Wendt C, Werner G, Altmann D, Witte W,. Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated me-thicillin-resistant strains. J Invest Dermatol 2008; 128: 2655-64.
7. Rietkotter J, Korber A, Grabbe S, Dissemond J,. Eradication of methicillin-resistant Staphylococcus aureus in a chronic wound by a new polyhexanide hydrogel. J Eur Acad Dermatol Venereol 2007; 21: 1416-7. (Pubitemid 350020153)
8. Reich-Schupke S, Geis G, Reising M, Altmeyer P, Stucker M,. MRSA in dermatology-Prospective epidemiological study in employees and patients of a dermatological department of a university hospital. J Dtsch Dermatol Ges 2010; 8: 607-13.
9. Reich-Schupke S, Warneke K, Altmeyer P, Stucker M,. Eradication of MRSA in chronic wounds of outpatients with leg ulcers is accelerated by antiseptic washesresults of a pilot study. Int J Hyg Environ Health 2010; 213: 88-92.
10. KVN. MRSA-Screening und -Sanierung weiter keine GKV-Leistung. Rund-schreiben. 2011: 12.
11. Vos MC, Behrendt MD, Melles DC, Mollema FP, de Groot W, Parlevliet G, Ott A, Horst-Kreft D, van Belkum A, Verbrugh HA,. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol 2009; 30: 977-84.
12. Cuny C, Friedrich A, Kozytska S, Layer F, Nubel U, Ohlsen K, Strommenger B, Walther B, Wieler L, Witte W,. Emergence of methicillin-resistant Staphylo-coccus aureus (MRSA) in different animal species. Int J Med Microbiol 2010; 300: 109-17.
13. Kock R, Harlizius J, Bressan N, Laerberg R, Wieler LH, Witte W, Deurenberg RH, Voss A, Becker K, Friedrich AW,. Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur J Clin Microbiol Infect Dis 2009; 28: 1375-82.
14. RKI. Auftreten und Verbreitung von MRSA in Deutschland 2008. Epide-miologisches Bulletin des RKI. 2009; 17.
15. Ni Eidhin D, Perkins S, Francois P, Vaudaux P, Hook M, Foster TJ,. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol 1998; 30: 245-57. (Pubitemid 28480176)
16. Al-Tawfiq JA, Aldaabil RA,. Community-acquired MRSA bacteremic necro-tizing pneumonia in a patient with scrotal ulceration. J Infect 2005; 51: e241-3. (Pubitemid 41683892)
17. Bahrain M, Vasiliades M, Wolff M, Younus F,. Five cases of bacterial endocarditis after furunculosis and the ongoing saga of community-acquired methicillin-resistant Staphylococcus aureus infections. Scand J Infect Dis 2006; 38: 702-7. (Pubitemid 44144733)
18. Contreras GA, Perez N, Murphy JR, Cleary TG, Heresi GP,. Empyema necessitans and acute osteomyelitis associated with community-acquired methicillin-resistant Staphylococcus au-reus in an infant. Biomedica 2009; 29: 506-12.
19. RKI. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus-aureus-Stämmen (MRSA) in Krankenhäusern und anderen medi-zinischen Einrichtungen. Mitteilung der Kommission für Krankenhaushy-giene und Infektionsprävention am RKI. Bundesgesundheitsblatt-Ge-sundheitsforschung-Gesundheits-schutz 1999; 42: 954-58.
20. RKI. Falldefinition des Robert Koch-Instituts zur neuen MRSA-Melde-pflicht gemä der Verordnung zur An-passung der Meldepflicht nach 7 IfSG. Bundesgesundheitsblatt 2007; 52: 962-63.
21. Mera RM, Suaya JA, Amrine-Madsen H, Hogea CS, Miller LA, Lu EP, Sahm DF, O'Hara P, Acosta CJ,. Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb Drug Resist 2011; 17 (2): 321-8.
22. RKI. Staphylokokken-Erkrankungen, insbesondere Infektionen durch MRSA. RKI-Ratgeber Infektions-krankheiten-Merkblätter für rzte 2009.